151 related articles for article (PubMed ID: 25732561)
1. Efficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical: a controlled clinical study.
Sorrentino G; Crispino P; Coppola D; De Stefano G
Drugs R D; 2015 Mar; 15(1):21-5. PubMed ID: 25732561
[TBL] [Abstract][Full Text] [Related]
2. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
[TBL] [Abstract][Full Text] [Related]
3. Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease.
Aller R; Laserna C; Rojo MÁ; Mora N; García Sánchez C; Pina M; Sigüenza R; Durà M; Primo D; Izaola O; de Luis D
Rev Esp Enferm Dig; 2018 Oct; 110(10):634-640. PubMed ID: 30032630
[TBL] [Abstract][Full Text] [Related]
4. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
Abenavoli L; Greco M; Nazionale I; Peta V; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):519-27. PubMed ID: 25617046
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
[TBL] [Abstract][Full Text] [Related]
6. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
7. The Synergic Effect of a Nutraceutical Supplementation Associated to a Mediterranean Hypocaloric Diet in a Population of Overweight/Obese Adults with NAFLD.
Chiurazzi M; Cacciapuoti N; Di Lauro M; Nasti G; Ceparano M; Salomone E; Guida B; Lonardo MS
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432436
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.
Hannah WN; Harrison SA
Dig Dis Sci; 2016 May; 61(5):1365-74. PubMed ID: 27052013
[TBL] [Abstract][Full Text] [Related]
9. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Cicero AFG; Colletti A; Bellentani S
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142943
[TBL] [Abstract][Full Text] [Related]
10. Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E.
D'Adamo E; Marcovecchio ML; Giannini C; de Giorgis T; Chiavaroli V; Chiarelli F; Mohn A
Free Radic Res; 2013 Mar; 47(3):146-53. PubMed ID: 23205728
[TBL] [Abstract][Full Text] [Related]
11. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
[TBL] [Abstract][Full Text] [Related]
12. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.
Yari Z; Rahimlou M; Eslamparast T; Ebrahimi-Daryani N; Poustchi H; Hekmatdoost A
Int J Food Sci Nutr; 2016 Jun; 67(4):461-9. PubMed ID: 26983396
[TBL] [Abstract][Full Text] [Related]
13. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
14. [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
Trappoliere M; Federico A; Tuccillo C; de Sio I; Di Leva A; Niosi M; D'Auria M; Loguercio C;
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):193-9. PubMed ID: 15990709
[TBL] [Abstract][Full Text] [Related]
15. Structured hypocaloric diet is more effective than behavioral therapy in reducing metabolic syndrome in Mexican postmenopausal women: a randomized controlled trial.
Perichart-Perera O; Balas-Nakash M; Muñoz-Manrique C; Legorreta-Legorreta J; Rodríguez-Cano A; Mier-Cabrera J; Aguilera-Pérez JR
Menopause; 2014 Jul; 21(7):711-20. PubMed ID: 24378762
[TBL] [Abstract][Full Text] [Related]
16. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
Loguercio C; Andreone P; Brisc C; Brisc MC; Bugianesi E; Chiaramonte M; Cursaro C; Danila M; de Sio I; Floreani A; Freni MA; Grieco A; Groppo M; Lazzari R; Lobello S; Lorefice E; Margotti M; Miele L; Milani S; Okolicsanyi L; Palasciano G; Portincasa P; Saltarelli P; Smedile A; Somalvico F; Spadaro A; Sporea I; Sorrentino P; Vecchione R; Tuccillo C; Del Vecchio Blanco C; Federico A
Free Radic Biol Med; 2012 May; 52(9):1658-65. PubMed ID: 22343419
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFα treatment.
Skroza N; Proietti I; Bernardini N; La Viola G; Nicolucci F; Pampena R; Tolino E; Zuber S; Mancini MT; Soccodato V; Balduzzi V; Potenza C
G Ital Dermatol Venereol; 2013 Dec; 148(6):661-5. PubMed ID: 24442048
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
19. The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.
Loguercio C; Federico A; Trappoliere M; Tuccillo C; de Sio I; Di Leva A; Niosi M; D'Auria MV; Capasso R; Del Vecchio Blanco C;
Dig Dis Sci; 2007 Sep; 52(9):2387-95. PubMed ID: 17410454
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.
Akcam M; Boyaci A; Pirgon O; Kaya S; Uysal S; Dundar BN
Int J Vitam Nutr Res; 2011 Nov; 81(6):398-406. PubMed ID: 22673924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
